arrow
P

Pin-Nan Cheng

College of Medicine
H指数:29
被引数:4,242

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C

高正常值范围及异常丙氨酸转氨酶水平与慢性丙型肝炎治疗后肝癌风险增加相关

2026-04-012
OAAI
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study

丙型肝炎病毒清除对伴有或不伴有活动性肝细胞癌患者的生存影响:一项全国性队列研究

2025-11-140
PRE
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry

丙型肝炎病毒清除对心血管风险的影响: 来自全国台湾丙型肝炎病毒登记处的真实经验

2025-05-240
OAAI
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program

治疗后FIB-4评分变化预测慢性丙型肝炎患者发生肝细胞癌:来自台湾丙型肝炎登记计划的研究结果

2025-02-280
OAAI
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C

Hong, C.-M.; Su, T.-H.; Hsu, S.-J.; Tseng, T.-C.; Liu, C.-H.; Yang, H.-C.; Kao, J.-H.; Chen, P.-J.; Cheng, P.-N.; Hung, C.-H.; 等. 将中性粒细胞与淋巴细胞比值加入Pre-DAA FIB-4不会增加对丙型肝炎患者新发肝并发症的预测价值。中华医事杂志. 2024; 已录用. [Google Scholar] [CrossRef] [PubMed]

2024-11-020
OAAI
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus
2024-11-011
OAAI
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
2024-07-016
OAAI
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals
2024-04-131
PRE
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
2024-01-213
OAAI
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
2023-03-278
OAAI